TI - Serum Soluble Programme Death-1 and Programme Death- Ligand 1 Identify Multiple Myeloma Patients: Serum sPDL-1 May Be a Prognostic Marker PT - Journal Article DP - 2019 TA - EJMI PG - 23-31 VI - 3 IP - 1 AID - 2019.17854 [doi] 4100 - https://dx.doi.org/10.14744/ejmi.2019.17854 SO - EURASIAN JOURNAL OF MEDICAL INVESTIGATION,2019 3(1): 23